Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|July 14, 2023
Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)Andres Valdivia, Purav P Vagadia, Guangxu Guo, et al.Journal of Medicinal Chemistry|May 13, 2026
Development of a Direct-to-Biology Platform to Discover Potent MNK InhibitorsPurav P Vagadia, Yingyu Mao, Frank Eckerdt, et al.Cancers|July 15, 2026
Potent Anti-Glioblastoma Effects of Next-Generation MNK InhibitorsCandice Mazewski, Ricardo E Perez, Purav P Vagadia, et al.Journal of Chemical Information and Modeling|October 1, 2019
Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential ChargesRama K Mishra, Kristine K Deibler, Matthew R Clutter, et al.European Journal of Medicinal Chemistry|October 8, 2025
Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cellsAndres Valdivia, Joshua L Zhu, Vanessa Hernandez, et al.Chemmedchem|February 2, 2019
Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 InhibitorsKristine K Deibler, Gary E Schiltz, Matthew R Clutter, et al.Mbio|August 27, 2020
Heterologous Expression of the Unusual Terreazepine Biosynthetic Gene Cluster Reveals a Promising Approach for Identifying New Chemical ScaffoldsLindsay K Caesar, Matthew T Robey, Michael Swyers, et al.Journal of Medicinal Chemistry|March 4, 2025
Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of LeukemiaPurav P Vagadia, Javier Izquierdo-Ferrer, Candice Mazewski, et al.The Journal of Organic Chemistry|December 15, 2018
Synthesis and Biological Evaluation of 6-[(1 R)-1-Hydroxyethyl]-2,4a( R),6( S),8a( R)-tetrahydropyrano-[3,2- b]-pyran-2-one and Structural Analogues of the Putative Structure of DiplopyroneNicholas C Lazzara, Robert J Rosano, Purav P Vagadia, et al.Molecular Cancer Therapeutics|December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignanciesElspeth M Beauchamp, Atul Jain, Matt Clutter, et al.Pageof 2